MAP3K7 and cardiac hypertrophy: Further, TAK1 activation exacerbated hypertrophic growth in the presence of pressure overload or neurohormonal stimuli, whereas the cardiac-specific overexpression of active TAK1 was sufficient to cause myocardial hypertrophy and dysfunction [50, 51].